FDA Investigator Steven J Libal

Steven J Libal has conducted inspections on 320 sites in 1 countries as of 20 Dec 2006. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
320
Last Inspection Date:
20 Dec 2006
Investigator Role:
FDA Investigator
Redica ID:
100003772
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Steven J Libal:
Alan D Centi, Aldo J Milone, Alia Legaux, Alice S Tsao, Alyssa R Favro, Amanda T Zick, Amy Kim, Andrew F Cohen, Andrew M Abramowitz, Ann B Okon, Ann Marie Karnick, Arduino Frankovic, Arthur G Hurst, Arthur S Williams, Jr, Ashley Polizzotto, Benton M Ketron, Bruce G Cooper, Cara M Minelli, Carley R Anderson, Carolyn J Cook, Catherine M Beer, Charisse K Green, Clinton V Giustra, Dana A Razzano, Daniel L Aisen, David A Laplante, David B Wieneke, David L Pearce, David R Lattuca, Deborah A Greco, Demitria J Xiradakis, Denise L Terzian, Diamond M Oden, Diane E Bruce, Dipesh K Shah, Donald G Gordon, Donald J Ullstrom, Douglas G Ng, Dr. Abhijit Raha, PhD, Dr. Robert C Horan, MD, Elizabeth H Davis, Elizabeth H Slazak, Eric S Myskowski, Erin L Nagel, Evelyn Taha, Frank J Koch, Gam S Zamil, Gary T Greco, George C Amedro, Gregory E Beichner, Harry J Brewer, Helen B Ricalde, Hilary K Wagner, Hugh M Mcclure, II, Iram R Hassan, PhD, Jacobson, James D Bridges, Jay B Shah, Jay T Wong, Jeanette L Mcginnis, Joanne M Schlossin, Joel R Merriman, John A Podsadowski, Johnna L Bleem, Jose Ohernandez Guzman, Joseph A Famiglietti, Joseph H Erdmann, Joseph Milcetic, Joshua C Schafer, Joshua D Lopez, Joshua L Gibbs, Joy P Matthias, Joyce A Williams, Juan Rjimenez Garcia, Judy Keihl, Juliana Falla, Julie Scoma, Karen L Kosar, Kathryn A Nagy, Kenneth G Klobus, Kevin A Gonzalez, Kimberly Y Smithson, Kyle J Spencer, Lauren E Blaser, Lawrence H Patrick, LCDR Chad N Thompson, Leena Thomas, Linda M Moore, Linda M Sacco, Lourdes Andujar, LT John M Mastalski, LTJG Bradley E Benasutti, Marcia D Fields, Margaret E Sarles, Marlene L Davis, Mary Alice B Garlipp, Mary F Finn, Mary M Finn, Matthew D Schnittker, Meghan L Fetterly, Meghan L Vanhouse, Meredith P Soehl, Investigator, Michael A Charles, Michael G Sinkevich, Michael R Dominick, Michael W Burd, Michelle L Dragon Nagel, Milan S Mcgorty, Mindy M Chou, Nicholas C Mendiola, Nicholas J Presto, Patricia A Clark, Paul E Stein, Perez, Peter M Trunk, Peter R Caparelli, Rajiv R Srivastava, Randi Lynn Bodoh, Randi Lynn Spencer, Raymond M Lam, Rene N Turgeon, Robert J Maffei, Robert J Veitch, Roseline N Boateng, Russ E Davis, Samina S Khan, Sasha M Latonis, Scott R Izyk, Scott R Leary, Shreya Shah, Sony Mathews, Tammy S Notto, Todd J Maushart, Tracy M Portelli, Valerie A Potopsingh, Valerie Jgrecek Trinh, Wayne J Meyer, Wendy M Stone, William C Brenneman, William M Rennells, William P Chilton

Steven J Libal's Documents

Publish Date Document Type Title
March, 2002 FDA 483 X-gen Pharmaceuticals Inc. - Form 483, 2002-03-13
July, 2006 EIR OSG Norwich Pharmaceuticals, Inc. - EIR, 2006-07-24
May, 2001 EIR Norwich Pharmaceuticals Inc. - EIR, 2001-05-18
May, 2004 EIR Marietta Corporation dba Voyant Beauty - EIR, 2004-05-07
July, 2003 FDA 483 Norwich Pharmaceuticals Inc. - Form 483, 2003-07-01
June, 2006 FDA 483 Marietta Corporation dba Voyant Beauty - Form 483, 2006-06-23
September, 2003 FDA 483 Andersen Pharmaceuticals LLC - Form 483, 2003-09-30
January, 2006 FDA 483 Andersen Pharmaceuticals LLC - Form 483, 2006-01-26
January, 2000 FDA 483 CWS CONTRACT PACKAGING - Form 483, 2000-01-20
April, 2001 EIR Pace Analytical Life Sciences, LLC. - EIR, 2001-04-05
September, 2003 FDA 483 Response Andersen Pharmaceuticals LLC - Form 483R, 2004-03-19
April, 2006 EIR XGen Pharmaceuticals DJB, Inc. - EIR, 2006-04-24
April, 2000 EIR MBR Waverly, LLC - EIR, 2000-04-19
November, 2003 EIR Norwich Pharmaceuticals Inc. - EIR, 2003-11-03
November, 2006 FDA 483 Kinney Drugs - Form 483, 2006-11-09

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more